[1]潘萍,李予,陈晓莉,等.控制性卵巢刺激中慢反应患者添加低剂量人绒毛膜促性腺激素的临床观察[J].中国计划生育和妇产科,2018,(9):76-79.
 PAN Ping,LI Yu,CHEN Xiao-li,et al.Clinical observation of low dose human chorionic gonadotropin in patients with suboptimal ovarian response in controlled ovarian stimulation[J].Chinese Journal of Family Planning & Gynecotokology,2018,(9):76-79.
点击复制

控制性卵巢刺激中慢反应患者添加低剂量人绒毛膜促性腺激素的临床观察
分享到:

《中国计划生育和妇产科》[ISSN:1674-4020/CN:51-1708/R]

卷:
期数:
2018年9期
页码:
76-79
栏目:
论著与临床
出版日期:
2018-09-25

文章信息/Info

Title:
Clinical observation of low dose human chorionic gonadotropin in patients with suboptimal ovarian response in controlled ovarian stimulation
作者:
潘萍李予陈晓莉黄佳李轶张清学杨冬梓*
中山大学孙逸仙纪念医院生殖中心
Author(s):
PAN PingLI YuCHEN Xiao-liHUANG JiaLI YiZHANG Qing-xueYANG Dong-zi*
Reproductive Medicine Centre,Memorial Hospital of Sun Yat-Sen University, Guangzhou Guangdong 510120,P.R.China
关键词:
卵巢慢反应绒毛膜促性腺激素控制性卵巢刺激
Keywords:
suboptimal ovarian responsehuman chorionic gonadotropincontrolled ovarian stimulation
分类号:
R 714.8
摘要:
目的探讨卵巢慢反应(suboptimal ovarian response,SOR)患者促排卵治疗中添加低剂量人绒毛膜促性腺激素(human chorionic gonadotropin,hCG)的效果。方法回顾性分析2011年3月至2015年12月于中山大学孙逸仙纪念医院采用促性腺激素释放激素激动剂长方案出现SOR的38例患者的临床资料,将38个SOR周期与22个自身对照周期进行比较。结果SOR周期的促性腺激素(gonadotropin,Gn)启动剂量、Gn使用天数、Gn总量和自身对照周期比较差异无统计学意义(P>005)。SOR周期启动日卵泡刺激素和hCG日黄体生成素水平均显著低于自身对照周期(P<005)。两组周期取消率、获卵数、2PN受精率、卵裂率、移植胚胎数、冷冻胚胎数、可利用胚胎数、种植率和临床妊娠率等指标比较,差异均无统计学意义(P>005)。 结论SOR者添加低剂量hCG可以改善卵巢反应性,并获得和卵巢正常反应周期相似的妊娠结局。
Abstract:
ObjectiveTo evaluate the effect of low-dose human chorionic gonadotropin (hCG) supplementation during controlled ovarian stimulation in patients with suboptimal ovarian response(SOR).MethodsRetrospective analyzed 38 patients with SOR in long-term gonadotropin-releasing hormone agonist regimen from March 2011 to December 2015 in Memorial Hospital of Sun Yat-Sen University. Compared 38 ovarian slow response cycles with 22 self-control cycles. ResultsThere were no differences in the starting dose, duration and consumption of gonadotropins between suboptimal response cycles and normal response cycles(P>005). The levels of follicle-stimulating hormone on the first day of ovarian stimulation and luteinizing hormone concentrations on hCG day were significantly lower in suboptimal response cycles than in the self-controlled cycles (P<005). Cycle cancelation rate, oocytes retrieved, 2PN fertilization rate, cleavage rate, transferred embryos, frozen embryos, available embryos, implantation rate and clinical rate were comparable between suboptimal response cycles and normal response cycles(P>005). ConclusionWith the supplementation of low-dose hCG, the patients of SOR could improve the ovarian response and achieve similar pregnancy outcome as compared with normal response cycle.

参考文献/References:

[1]张波.控制性卵巢刺激中卵巢慢反应的发生原因及处理方法 [J].生殖医学杂志,2013,22(10):770-774. [2]乔杰,马彩虹,刘嘉茵,等.辅助生殖促排卵药物治疗专家共识 [J].生殖与避孕,2015,35(4):211-223. [3]尹倩倩,李予,黄佳,等.LH受体基因rsl3405728位点多态性与卵巢慢反应的相关性 [J].中华医学遗传学杂志,2015,32(6):840-843. [4]FERRARETTI A P, GIANAROLI L, MAGLI M C, et al. Exogenous luteinizing hormone in controlled ovarian hyperstimulation for assisted reproduction techniques [J]. Fertility and Sterility, 2004, 82 (6): 1521-1526. [5]DE PLACIDO G, ALVIGGI C, PERINO A, et al. Recombinant human LH supplementation versus recombinant human FSH(rFSH)step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH.A multicentre,prospective,randomized controlled trial [J]. Human Reproduction, 2005, 20 (2): 390-396. [6]李红真,龚斐,蔡素芬,等.卵巢刺激慢反应患者补充重组黄体生成素的疗效评价 [J].生殖医学杂志,2013,22(2):92-96. [7]帅振虹,连方.补充黄体生成素对控制性超促排卵过程中卵巢慢反应患者临床结局的影响 [J].现代妇产科进展,2014,23(9):716-718, 723. [8]潘萍,杨冬梓.低剂量绒促性素与控制性卵巢刺激 [J].实用妇产科杂志,2016,32(1):19-22. [9]Ezcurra D, Humaidan P. A review of luteinising hormone and human chorionic gonadotropin when used in assisted reproductive technology [J]. Reprod Biol Endocrinol, 2014,12(1):95. [10]CHECA M A, JOSE ESPINOS J, REQUENA A. Efficacy and safety of human chorionic gonadotropin for follicular phase stimulation in assisted reproduction: a systematic review and meta-analysis [J]. Fertility and Sterility, 2012, 97 (6): 1343. [11]Martins WP, Vieira AD, Figueiredo JB, et al. FSH replaced by low-dose hCG in the late follicular phase versus continued FSH for assisted reproductive techniques [J]. Cochrane Database Syst Rev,2013,3(3):CD010042. [12] 杨子凌,姜宏,倪丰.小剂量绒促性素在抵抗型慢反应患者中的应用 [J].实用妇产科杂志,2016,32(11):859-863.

相似文献/References:

[1]杨学妞,张觇宇.动态血清孕酮及β-HCG值对早期异常妊娠的临床意义[J].中国计划生育和妇产科,2010,(06):0.
 YANG Xue-niu,ZHANG Chan-yu.[J].Chinese Journal of Family Planning & Gynecotokology,2010,(9):0.
[2]伍洁华,曾少颜.1例注射绒毛膜促性腺激素后严重反应的护理[J].中国计划生育和妇产科,2011,(03):0.
[3]赵振钏*,亓蓉,吴小华,等.卵巢刺激慢反应患者补充生长激素的疗效评价[J].中国计划生育和妇产科,2019,(7):41.
 ZHAO Zhen-chuan*,QI Rong,WU Xiao-hua,et al.Efficacy evaluation of supplementation of growth hormone in patients with suboptimal ovarian response[J].Chinese Journal of Family Planning & Gynecotokology,2019,(9):41.

更新日期/Last Update: 2018-09-25